KBR vs NBIX · P/E 16, rev $3.91B vs P/E 45, rev $1.77B
KBR Inc (KBR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
KBR Inc (KBR) is a engineering & construction company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported KBR revenue for 2026-07-03 was $3.91B. Net income was $198.0M. KBR currently screens at market cap $6.19B and trailing P/E 16.0.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
KBR currently screens at market cap $6.19B and trailing P/E 16.0. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the KBR and NBIX stock pages for the full models.
Not investment advice.